Location History:
- Garching, DE (1991 - 1993)
- Unterfinning, DE (1993)
- Finning, DE (1996 - 2011)
Company Filing History:
14 out of 1,164 
11 out of 1,650 
2 out of 480 
Years Active: 1991-2025
Title: Erasmus Huber: Innovator in Biopharmaceuticals
Introduction
Erasmus Huber is a distinguished inventor based in Finning, Germany, with an impressive portfolio of 26 patents. His groundbreaking work primarily focuses on the development of protease inhibitors and their applications in immunoassays, contributing significantly to the fields of biochemistry and pharmaceuticals.
Latest Patents
Huber's latest patents revolve around the innovative use of activated haptens in the creation of immunogens specifically targeting HIV protease inhibitors. His patents include "Protease Inhibitor Conjugates and Antibodies Useful in Immunoassay" and "Saquinavir Conjugates and Antibodies Useful in Immunoassay". These inventions detail the use of novel haptens with an activated functionality at the central, non-terminal hydroxyl group. Notably, his work outlines monoclonal antibodies that are specific to saquinavir, exhibiting less than 10% cross-reactivity with other protease inhibitors, demonstrating a remarkable advancement in specificity for diagnostic purposes.
Career Highlights
Throughout his career, Erasmus Huber has made substantial contributions while working with prestigious companies such as Boehringer Mannheim GmbH and Roche Diagnostics Operations, Inc. His role in these organizations has allowed him to further develop his innovative ideas and ensure their application in the biopharmaceutical sector.
Collaborations
Huber’s innovative journey has been enriched by collaborations with esteemed colleagues, including Gerald F. Sigler and Eva Hoess. Working alongside such talented individuals has facilitated the advancement of his research and the successful filing of numerous patents.
Conclusion
Erasmus Huber’s contributions to the field of biopharmaceuticals showcase his innovative spirit and commitment to advancing medical science. With 26 patents to his name, including substantial advancements in immunoassays for HIV protease inhibitors, Huber continues to be a pivotal figure in the fight against infectious diseases. His work not only reflects a dedication to scientific advancement but also highlights the importance of collaboration in innovation.